The Future of Nonclinical Studies in the Age of COVID-19

Date

Monday, September 28, 2020
11:00 AM - 12:00 PM EDT (5:00 PM - 6:00 PM CEST)

Location

Online Webinar
group of scientists working at the laboratory

Overview

Technological advances over the past 20 years have created the opportunity to assess, quantify, and routinely monitor research activities without a need to be physically present. Coronavirus has only intensified the discussion about whether to further implement digital technologies and processes into nonclinical studies.

Join us for a spirited panel discussion about possible approaches, limitations, concerns, and benefits of using remote monitoring for nonclinical research.

 

Scientific Moderator and Presenters

Kevin McDorman, DVM, PhD, Diplomate, ACVP
Corporate Vice President, Global Pathology Services
Charles River

Elizabeth McInnes, BVSc, PhD, FRC Path, MRCVS, FIATP, MBA
Head of Toxicologic Pathology
Syngenta

Armando Irizarry Rovira, DVM, PhD, Diplomate, ACVP
Director of Investigative Toxicology, Nonclinical Study Management, and Pathology
Eli Lilly and Company

 

View the other webinars in the series:

 
Have a scheduling conflict? Sign up even if you can't make it; we'll share the recording after.
 

During this time of uncertainty, we are focused on providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.